KD Logo

Insider Selling: KUPPUSAMY KARTHIK, Quest Diagnostics, Inc. [DGX] SVP, Clinical Solutions divested 1,760 shares

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Quest Diagnostics, Inc. shares valued at $246,400 were sold by KUPPUSAMY KARTHIK on Apr 29 ’24. At $140.00 per share, KUPPUSAMY KARTHIK sold 1,760 shares. The insider’s holdings dropped to 13,435 shares worth approximately $1.86 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, PREVOZNIK MICHAEL E sold 5,611 shares, netting a total of over 706,313 in proceeds. Following the sale of shares at $125.88 each, the insider now holds 38,478 shares.

Before that, Doherty Catherine T. had sold 1,187 shares from its account. In a trade valued at $149,420, the EVP, Regional Businesses traded Quest Diagnostics, Inc. shares for $125.88 each. Upon closing the transaction, the insider’s holdings decreased to 1,187 shares, worth approximately $9.45 million.

As published in their initiating research note from Leerink Partners on February 26, 2024, Quest Diagnostics, Inc. [DGX] has been a Market perform and the price target has been revised to $135. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early February. As of January 03, 2024, Barclays has initiated its “an Equal weight” rating for DGX. Earlier on December 12, 2023, BofA Securities upgraded its rating. Their new recommendation was “a Buy” for DGX stock which previously was a “a Neutral”.

Analyzing DGX Stock Performance

During the last five days, there has been a drop of approximately -0.45%. Over the course of the year, Quest Diagnostics, Inc. shares have jumped approximately 0.23%. Shares of the company reached a 52-week high of $145.62 on 05/20/24 and a 52-week low of $123.04 on 02/01/24. A 50-day SMA is recorded $137.45, while a 200-day SMA reached $131.90. Nevertheless, trading volume fell to 0.76 million shares from 0.76 million shares the previous day.

Support And Resistance Levels for Quest Diagnostics, Inc. (DGX)

According to the 24-hour chart, there is a support level at 136.58, which, if violated, would cause prices to drop to 134.97. In the upper region, resistance lies at 139.05. The next price resistance is at 139.91. RSI (Relative Strength Index) is 46.30 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.66, which suggests the price will decrease in the coming days. Percent R is at 70.31%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular